Signum U.S. Healthcare,  Inc.

· Better quality of life during and after treatment: - no need for an invasive head frame - typically no hospital stays - few visits to hospital - short or no recovery periods

· Treatment is available for tumors previously considered inoperable. -Reduces the risk of complications that are sometimes associated with conventional surgery

· Dosage distributions adjusted to minimize radiation exposure to surrounding healthy tissue

· Less pain

· No blood loss

· No scalpel

· Mild sedation during treatment

· Usually performed as an outpatient procedure

More Frequently Asked Questions

CyberKnife®  technology is approved by the U.S. Food and Drug Administration (FDA) to treat tumors and lesions throughout the body. Signum intends to use the CyberKnife®  to treat tumors of the brain, lung, spine, pancreas, liver, prostate, head and neck, including:

· Benign tumours

· Malignant tumors

· Vascular malformations

· Functional disorders

What can the CyberKnife® treat?

What are the benefits for patients?

E-mail: info@signumhealth.com